Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma

Keyphrases

• Time-resolved 100%
• Glioblastoma 100%
• Single-cell Transcriptomics 100%
• Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) 100%
• Immune Trajectory 100%
• Monocytes 50%
• Tumor Microenvironment 50%
• Natural Killer Cells 50%
• Cell State 50%
• Inflammatory Macrophages 50%
• Tumor Infiltration 50%
• Stamping 50%
• Genomic Technologies 50%
• Technology Support 50%
• Cellular Dynamics 50%
• Molecular Trajectory 50%
• Circulating Immune Cells 50%
• Arginase-1 (Arg-1) 50%
• Immune Microenvironment 50%
• Cell State Transition 50%
• Differentiation Trajectory 50%
• Single-cell Technologies 50%
• Empirical Measurement 50%
• Immunosuppressive Macrophages 50%
• Transcriptomic Dynamics 50%
• TGF-β1 Signaling 50%
• Myeloid Checkpoint 50%
• Immune Cell Tracking 50%

Immunology and Microbiology

• Macrophage 100%
• Transcriptomics 100%
• Myeloid 50%
• Immunotherapy 50%
• Upregulation 50%
• Immunosuppressive Drug 50%
• Natural Killer Cell 50%
• Immunocompetent Cell 50%

Neuroscience

• Macrophage 100%
• Transcriptomics 100%
• Myeloid 50%
• In Vivo 50%
• Immunosuppressive Drug 50%
• Immunotherapy 50%
• Natural Killer Cell 50%